What we're reading, July 4, 2016: a hospital is offering free housing to get super-utilizers out of the emergency room; campaigns for patients to gain access to stem cell treatments are gaining momentum; and why hospital/physician integration and consolidation probably won't lower costs.
The University of Illinois Hospital is offering free housing for frequent users of the emergency room. The hospital is using $250,000 of its own money on a pilot to get patients who are considered “super-utilizers” out of the emergency room and into an apartment, reported NPR. The program provides 25 patients with an apartment and a case manager to help them schedule doctor’s appointments instead of using the emergency room. Instead of paying $3000 per day for hospital care, the hospital is only paying $1000 a month for an apartment.
Campaigns for patients to gain access to stem cell treatments are gaining momentum across the country. According to STAT, a bill was introduced in Washington, DC, for the FDA to grant conditional approval for stem cell treatments without data from Phase 3 trials, and a state agency in California is enlisting patients to push for the federal regulatory process to be sped up. However, critics warn that faster approvals could undermine the FDA’s authority. The FDA maintains that stem cell treatment for most conditions still remains “largely unproven.”
The hope that hospital/physician integration will lower healthcare expenses is probably wishful thinking, writes physician Peter Ubel, MD, in a piece for Forbes. While Medicare is encouraging consolidation into entities like accountable care organizations and integration similar to that of the Kaiser Permanente system, it could end up costing a lot of money when hospitals and physicians join forces. The primary reason physicians join hospitals is not to achieve greater efficiencies, but to give them greater negotiating power with insurers, which results in higher costs for patients.
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More